sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Congestive Heart Failure (CHF) Treatment Devices Market by Product Type (Pacemakers (Implantable, Pacemakers), CRT (CRT-P, CRT-D), ICDs (T-ICDs, S-ICDs), VADs (LVAD, RVAD, BIVAD)) - Global Opportunity Analysis and Industry Forecast, 2015 - 2022

Congestive Heart Failure (CHF) Treatment Devices Market by Product Type...

Home / Categories / Healthcare
Congestive Heart Failure (CHF) Treatment Devices Market by Product Type (Pacemakers (Implantable, Pacemakers), CRT (CRT-P, CRT-D), ICDs (T-ICDs, S-ICDs), VADs (LVAD, RVAD, BIVAD)) - Global Opportunity Analysis and Industry Forecast, 2015 - 2022
Congestive Heart Failure (CHF) Treatment...
Report Code
RO1/113/1042

Publish Date
01/May/2016

Pages
135
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.5.1 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond what to expect by 2027 ($Million)

2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 High competition and fragmented market moderates the power of the suppliers
3.3.2 Scattered and large number of buyers moderates their bargaining power
3.3.3 High capital investment moderates the threat of new entrants
3.3.4 High intensity of rivalry
3.3.5 Unavailability of substitutes lowers the threat of substitutes

3.4 Market share analysis, 2015
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Growing incidences of congestive heart failures
3.5.1.2 Technological advancements in CHF treatment devices
3.5.1.3 Increasing patient awareness
3.5.1.4 Presence of high-unmet medical needs

3.5.2 Restraints

3.5.2.1 Limited insurance coverage and high cost of the CHF treatment devices
3.5.2.2 unfavorable preference to pharmaceutical interventions (drugs) over CHF treatment devices

3.5.3 Opportunities

3.5.3.1 Lucrative opportunities in emerging economies
3.5.3.2 Development of new MRI-labeled devices

CHAPTER 4 WORLD CHF TREATMENT DEVICES MARKET, BY PRODUCT

4.1 Pacemakers

4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast
4.1.4 Implantable Pacemakers

4.1.4.1 Market size and forecast

4.1.5 External Pacemakers

4.1.5.1 Market size and forecast

4.2 Cardiac resynchronization therapy (CRT)

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 CRT-P (CRT with pacemaker function)

4.2.4.1 Market size and forecasts

4.2.5 CRT-D (CRT with pacemaker and ICD function)

4.2.5.1 Market size and forecasts

4.3 Implantable cardioverter defibrillators (ICDs)

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities

4.3.2.1 Market size and forecast

4.3.3 Transvenous implantable cardioverter defibrillator (T-ICDs)

4.3.3.1 Market size and forecasts

4.3.4 Subcutaneous implantable cardioverter defibrillator (S-ICDs)

4.3.4.1 Market size and forecasts

4.4 Ventricular Assist Devices (VADs)

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Left Ventricular assist device (LVAD)

4.4.4.1 Market size and forecasts

4.4.5 Right ventricular assist device (RVAD)

4.4.5.1 Market size and forecasts

4.4.6 Biventricular Assist Device (BIVAD)

4.4.6.1 Market size and forecasts

CHAPTER 5 WORLD CHF TREATMENT DEVICES MARKET, BY GEOGRAPHY, 2015-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 U.S.

5.2.4.1 Market size and forecast

5.2.5 Canada

5.2.5.1 Market size and forecast

5.2.6 Mexico

5.2.6.1 Market size and forecast

5.3 Europe

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.3.4 Germany

5.3.4.1 Market size and forecast

5.3.5 France

5.3.5.1 Market size and forecast

5.3.6 U.K.

5.3.6.1 Market size and forecast

5.3.7 Rest of Europe

5.3.7.1 Market size and forecast

5.4 Asia-Pacific

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 India

5.4.4.1 Market size and forecast

5.4.5 China

5.4.5.1 Market size and forecast

5.4.6 Japan

5.4.6.1 Market size and forecast

5.4.7 Rest of Asia-Pacific

5.4.7.1 Market size and forecast

5.5 LAMEA

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.5.4 Latin America

5.5.4.1 Market size and forecast

5.5.5 Middle East

5.5.5.1 Market size and forecast

5.5.6 Africa

5.5.6.1 Market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Abiomed, Inc.

6.1.1 Company overview
6.1.2 Operating business segments
6.1.3 Business performance
6.1.4 Key strategic moves & developments
6.1.5 SWOT analysis

6.2 Berlin Heart GmbH

6.2.1 Company overview
6.2.2 Operating business segments
6.2.3 Key strategic move & development
6.2.4 SWOT analysis

6.3 Biotronik SE & Co. KG

6.3.1 Company overview
6.3.2 Operating business segments
6.3.3 Key strategic moves & developments
6.3.4 SWOT analysis

6.4 Boston Scientific Corporation

6.4.1 Company overview
6.4.2 Operating business segments
6.4.3 Business performance
6.4.4 Key strategic moves & developments
6.4.5 SWOT analysis

6.5 HeartWare International, Inc.

6.5.1 Company overview
6.5.2 Operating business segments
6.5.3 Business performance
6.5.4 Key strategic moves & developments
6.5.5 SWOT analysis

6.6 Jarvik Heart, Inc.

6.6.1 Company overview
6.6.2 Operating business segments
6.6.3 Key strategic moves & developments
6.6.4 SWOT analysis

6.7 LivaNova PLC

6.7.1 Company overview
6.7.2 Operating business segments
6.7.3 Business performance
6.7.4 Key strategic moves & developments
6.7.5 SWOT analysis

6.8 Medtronic plc

6.8.1 Company overview
6.8.2 Operating business segments
6.8.3 Business performance
6.8.4 Key strategic moves & developments
6.8.5 SWOT analysis

6.9 ReliantHeart, Inc.

6.9.1 Company overview
6.9.2 Operating business segments
6.9.3 Key strategic moves & developments
6.9.4 SWOT analysis

6.10 St. Jude Medical, Inc.

6.10.1 Company overview
6.10.2 Operating business segments
6.10.3 Business performance
6.10.4 Key strategic moves & developments
6.10.5 SWOT analysis

List of Figures

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com